CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 160 filers reported holding CRISPR THERAPEUTICS AG in Q4 2018. The put-call ratio across all filers is 1.91 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,267,136 | -49.1% | 22,571 | -59.0% | 0.05% | -47.4% |
Q1 2023 | $2,491,268 | +11.3% | 55,080 | 0.0% | 0.10% | +11.8% |
Q4 2022 | $2,239,002 | -37.8% | 55,080 | 0.0% | 0.08% | -42.2% |
Q3 2022 | $3,599,000 | +7.5% | 55,080 | 0.0% | 0.15% | +11.4% |
Q2 2022 | $3,347,000 | -3.2% | 55,080 | 0.0% | 0.13% | +9.1% |
Q1 2022 | $3,457,000 | -17.2% | 55,080 | 0.0% | 0.12% | -9.7% |
Q4 2021 | $4,174,000 | -77.0% | 55,080 | -66.1% | 0.13% | -77.1% |
Q3 2021 | $18,170,000 | -30.9% | 162,337 | 0.0% | 0.58% | -31.5% |
Q2 2021 | $26,281,000 | +42.9% | 162,337 | +7.5% | 0.85% | +34.9% |
Q1 2021 | $18,394,000 | +57.6% | 150,958 | +98.1% | 0.63% | +54.4% |
Q4 2020 | $11,670,000 | +83.1% | 76,222 | 0.0% | 0.41% | +71.5% |
Q3 2020 | $6,375,000 | +13.8% | 76,222 | 0.0% | 0.24% | +12.2% |
Q2 2020 | $5,602,000 | +73.3% | 76,222 | 0.0% | 0.21% | +45.9% |
Q1 2020 | $3,233,000 | -30.4% | 76,222 | 0.0% | 0.15% | -17.0% |
Q4 2019 | $4,642,000 | +11.7% | 76,222 | -24.8% | 0.18% | -2.8% |
Q3 2019 | $4,154,000 | -50.5% | 101,336 | -43.2% | 0.18% | -47.2% |
Q2 2019 | $8,400,000 | +31.8% | 178,348 | 0.0% | 0.34% | +32.4% |
Q1 2019 | $6,371,000 | +25.0% | 178,348 | 0.0% | 0.26% | +18.8% |
Q4 2018 | $5,095,000 | -35.6% | 178,348 | 0.0% | 0.22% | -24.0% |
Q3 2018 | $7,910,000 | -24.5% | 178,348 | 0.0% | 0.29% | -27.9% |
Q2 2018 | $10,480,000 | +62.4% | 178,348 | +26.3% | 0.40% | +58.6% |
Q1 2018 | $6,454,000 | – | 141,191 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |